Taiyen Biotech Co., Ltd. (1737.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In TWD
| Market Cap | 6.24B |
| Enterprise Value | 5.11B |
| P/E Ratio | 16.04 |
| PEG Ratio | 1.82 |
| Price/Sales Ratio | 1.94 |
| Price/Book Ratio | 0.92 |
| Enterprise/Revenue | 1.54 |
| Enterprise/EBITDA | 7.15 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.12 |
| Operating Margin | 0.16 |
| Return On Assets | 0.05 |
| Return On Equity | 0.06 |
| Revenue | 3.31B |
| Revenue/Share | 16.31 |
| Gross Profit | 1.34B |
| EBITDA | 709.15M |
| Net Income | 399.87M |
| Diluted EPS | 2 |
| Total Cash | 1.81B |
| Total Cash/Share | 9.03 |
| Total Debt | 203.16M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 3.25 |
| Book Value Per Share | 34.38 |
| 52-Week Change | -2.46 |
| 52-Week High | 33.45 |
| 52-Week Low | 30.8 |
| Moving Average 50 Days | 31.71 |
| Moving Average 200 Days | 31.75 |
| Average Volume | 121,948 |
| Shares Outstanding | 200M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 1.3 |
| Trailing Annual Dividend Yield | 4.09 |
| Payout Ratio | 0.65 |
| Last Split Factor | 719:1000 |
| Last Split Date | December 16, 2013 |